健走对轻中度焦虑性抑郁障碍的干预效果观察

Observation on the intervention effect of brisk walking on mild to moderate anxiety-depression disorder

目的 探讨健走对轻中度焦虑性抑郁障碍的干预效果。方法 200例轻中度焦虑性抑郁障碍患者,随机分为对照组和研究组,各100例。对照组给予氟哌噻吨美利曲辛片治疗,研究组参加当年的“万步有约”健走大赛。比较两组疗效,干预前后的抑郁自评量表(SDS)评分、焦虑自评量表(SAS)评分、汉密尔顿抑郁量表(HAMD)评分,不良反应发生率。结果 两组总有效率比较,差异无统计学意义(P>0.05)。干预前,观察组SDS、SAS评分分别为(60.22±3.49)、(56.94±5.13)分,对照组分别为(60.45±3.38)、(56.64±5.10)分;干预后,观察组SDS、SAS评分分别为(44.93±5.10)、(44.03±5.75)分,对照组分别为(45.11±5.78)、(44.91±6.05)分。干预后,两组SDS、SAS评分均低于干预前,差异有统计学意义(P<0.05)。干预后,两组SDS、SAS评分组间比较,差异无统计学意义(P>0.05)。干预前,观察组HAMD评分为(19.19±2.98)分,对照组为(19.57±2.48)分;干预后观察组HAMD评分为(10.70±2.81)分,对照组为(10.34±2.45)分。干预后,两组HAMD评分均低于干预前,差异有统计学意义(P<0.05)。干预后,两组HAMD评分组间比较,差异无统计学意义(P>0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论 健走能有效缓解轻中度焦虑性抑郁患者的抑郁焦虑情绪,安全性较好,可作为轻中度焦虑性抑郁障碍患者的治疗或辅助手段在临床上推广应用。

Objective To discuss the intervention effect of brisk walking on mild to moderate anxietydepression disorder.Methods A total of 200 patients with mild to moderate anxiety-depression disorder were randomly divided into control group and research group,with 100 cases in each group.The control group was treated with flupentixol and melitracen tablets,and the research group participated in the"Ten thousand Steps"walking competition that year.Both groups were compared in terms of efficacy,self-rating depression scale(SDS)score,self-rating anxiety scale(SAS)score,Hamilton depression scale(HAMD)score before and after intervention,and the incidence of adverse reactions.Results There was no statistically significant difference in total effective rate between the two groups(P>0.05).Before intervention,SDS and SAS scores of the observation group were(60.22±3.49)and(56.94±5.13)points,and those of the control group were(60.45±3.38)and(56.64±5.10)points.After intervention,SDS and SAS scores of the observation group were(44.93±5.10)and(44.03±5.75)points,and those of the control group were(45.11±5.78)and(44.91±6.05)points.After intervention,SDS and SAS scores in both groups were lower than those before intervention in this group,and the difference was statistically significant(P<0.05).After intervention,there was no statistically significant difference in SDS and SAS scores between the two groups(P>0.05).Before intervention,HAMD score was(19.19±2.98)points in the observation group,and(19.57±2.48)points in the control group;after intervention,the HAMD score was(10.70±2.81)points in the observation group,and(10.34±2.45)points in the control group.After intervention,the HAMD scores of both groups were lower than those of this group before intervention,and the difference was statistically significant(P<0.05).After intervention,there was no statistically significant difference between the two groups in terms of HAMD scores(P>0.05).The incidence of adverse reactions was compared between the two groups,the difference was not statistically significant(P>0.05).Conclusion Brisk walking can effectively relieve depression and anxiety in patients with mild to moderate anxiety-depression disorders.It has high safety,and can be clinically promoted as a treatment or auxiliary method for patients with mild to moderate anxiety-depression disorder.